In this study, we investigated the occurrence of the BRCA1 c.-107A > T SNV in 178 patients, most of them with triple-negative breast cancer, who tested positive for BRCA1 promoter hypermethylation by MLPA in their breast or ovarian tumor. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.